Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Tretinoin data

ARGS (The Woodlands, Texas) presented preliminary Phase I data in 35 patients who had failed

Read the full 151 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE